Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

STEM Healthcare

This page shows the latest STEM Healthcare news and features for those working in and with pharma, biotech and healthcare.

STEM Healthcare founder Rob Wood secures a 25% stake in performance-io

STEM Healthcare founder Rob Wood secures a 25% stake in performance-io

Wood, who previously worked as a director at pharma company AstraZeneca, founded and sold commercial, marketing and medical audit firm STEM to UDG Healthcare in 2016 in a deal worth £84m. ... STEM’s service offerings include quantifying and

Latest news

  • UDG Healthcare acquires STEM Marketing for £84m UDG Healthcare acquires STEM Marketing for £84m

    Buying STEM Marketing will expand the commercial and clinical service offering of UDG's Ashfield business and complement its Ashfield Healthcare Communications global offering. ... Rob Wood, chief executive of STEM, said: “We are delighted to begin an

  • Realising the potential of cell therapies Realising the potential of cell therapies

    a route to providing stem cells that are a perfect genetic match for the patient. ... The UK leads the world in healthcare, finance and stem cell R&D,” he added.

  • Succinct forms market access partnership with Royal Marsden Succinct forms market access partnership with Royal Marsden

    Succinct Healthcare Communications has entered a market access partnership with London-based cancer research and treatment centre The Royal Marsden (TRM) NHS Foundation Trust. ... The project will focus on sharing knowledge between The Royal Marsden and

  • Hard to swallow

    Pfizer's medicines have been heavily targeted by counterfeiters over the years and the company has worked extensively with regulators, law enforcement authorities and healthcare professionals to stem the tide. ... And that has to be a good thing. The

  • NHS explains cancer drug findings

    NHS Choices clarifies published research which claims its possible to identify chemicals that specifically kill cancer stem cells. ... NHS Choices clarifies published research which claims it's possible to identify chemicals that specifically kill cancer

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Anticipating the future in healthcare Anticipating the future in healthcare

    Sector limits will merge and value creation will change. Tomorrow's healthcare ecosystem. ... Pioneering new technology. Case study: Providing access to gene and stem-cell therapies.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Simon Doyle joins STEM Simon Doyle joins STEM

    Benchmarking company STEM has appointed Simon Doyle as its new vice president of global customer relations and development. ... further drive value to STEM’s clients.

  • STEM Healthcare bolsters its EU5 team STEM Healthcare bolsters its EU5 team

    Adds four new hires to support growth across the region. STEM Healthcare - formerly STEM Marketing - has made a number of senior appointments across its EU5 team to sustain growth and underpin ... He joins STEM from his most recent role as a director at

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...

Quick links